Drug class in one race

Mesothelin/MSLN (activator) / HLA-A*02 (blocker) drugs for Non-Small Cell Lung Cancer

2 tracked Mesothelin/MSLN (activator) / HLA-A*02 (blocker) drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the Mesothelin/MSLN (activator) / HLA-A*02 (blocker) page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.

← all Mesothelin/MSLN (activator) / HLA-A*02 (blocker) drugs